Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Histoplasmosis.

J W Dijkstra1

  • 1Department of Dermatology, Cleveland Clinic Foundation, Ohio.

Dermatologic Clinics
|April 1, 1989
PubMed
Summary
This summary is machine-generated.

Histoplasmosis, a fungal infection caused by Histoplasma capsulatum, typically resolves without treatment. Severe pulmonary cases, however, necessitate Amphotericin B therapy, the preferred treatment.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Childhood vitiligo successfully treated with bath PUVA.

Pediatric dermatology·1998
Same author

Early onset pretibial myxedema in the absence of ophthalmopathy: a morphologic evolution.

Cutis·1996
Same author

UVB blocking effect of calcipotriene ointment 0.005%.

Journal of the American Academy of Dermatology·1996
Same author

Effects of sarafloxacin hydrochloride on human enteric bacteria under simulated human gut conditions.

The veterinary quarterly·1995
Same author

Associations of pemphigus and autoimmune disease with malignancy or thymoma.

International journal of dermatology·1994
Same author

Amiodarone-induced linear IgA disease.

Journal of the American Academy of Dermatology·1994
Same journal

The Evidence Is In: Devices and Biologics Reshaping Modern Dermatology.

Dermatologic clinics·2026
Same journal

Energy-Based Devices for Body Contouring.

Dermatologic clinics·2026
Same journal

Microfocused Ultrasound with Visualization for Skin Tightening: Clinical Applications, Safety, and Technical Considerations.

Dermatologic clinics·2026
Same journal

Devices in Onychomycosis: A Status Update.

Dermatologic clinics·2026
Same journal

Acne Laser Devices in Dermatology.

Dermatologic clinics·2026
Same journal

Fractional Laser Therapy for Androgenetic Alopecia: Mechanisms, Clinical Evidence, and Practical Implementation.

Dermatologic clinics·2026
See all related articles

Area of Science:

  • Mycology
  • Infectious Diseases
  • Pulmonology

Background:

  • Histoplasmosis is an infection caused by the dimorphic fungus Histoplasma capsulatum.
  • It is generally a self-limiting condition in immunocompetent individuals.
  • Severe presentations, particularly acute pulmonary histoplasmosis, can pose significant health risks.

Purpose of the Study:

  • To outline the typical course and treatment considerations for histoplasmosis.
  • To identify when therapeutic intervention is necessary for Histoplasma capsulatum infections.
  • To highlight the primary antifungal agent for severe cases.

Main Methods:

  • Review of clinical presentation and natural history of histoplasmosis.
  • Analysis of treatment guidelines for fungal infections.

Related Experiment Videos

  • Identification of the gold-standard therapy for severe acute pulmonary histoplasmosis.

    • Main Results:

    • Most cases of histoplasmosis are self-limited and do not require antifungal treatment.
    • Severe acute pulmonary histoplasmosis is an exception requiring medical intervention.
    • Amphotericin B is established as the primary treatment of choice for severe infections.

    Conclusions:

    • While often benign, histoplasmosis management hinges on disease severity.
    • Prompt recognition of severe pulmonary disease is crucial for timely intervention.
    • Amphotericin B remains the cornerstone of treatment for severe histoplasmosis.